Application of immunohistochemistry to assess the presence of prognostic tissue markers is used widely. The quantitation of these markers may be hampered by a time-related loss of antigenicity in formalin-fixed paraffin- embedded tissue stored on glass slides. Potential loss of immunohistochemical staining intensity was studied on prostatic needle biopsy sections stored for a maximum of 4 years with antibodies against p27(kip1), CD-44s, MIB-1, and androgen receptor (AR). In benign tissue, the positive/total ratio for p27(kip1) was determined, while CD-44s staining intensity was assessed semiquantitatively. For MIB-1 and AR, nuclear staining intensity was assessed using computed image analysis. An exponential and significant decay of immunor...
Pre-analytic variables, specifically cold ischemic time, have been implicated as key variables in th...
We studied the usefulness of a p63/P504S immunostain “cocktail ” in evaluation of prostate biopsy sp...
Background: Prostate cancer is a very common, but particularly heterogenic cancer form. Whilst some ...
Application of immunohistochemistry to assess the presence of prognostic tissue markers is used wide...
Immunohistochemical analysis of molecular targets in clinical tissues is increasingly becoming centr...
Background: To test the value of immunohistochemistry (IHC) staining in prostate biopsies for change...
Sectioning a whole tissue microarrray (TMA block) and storing the sections maximizes the number of s...
Sectioning a whole tissue microarrray (TMA block) and storing the sections maximizes the number of s...
Antigen decay in archival formalin-fixed paraffin-embedded (FFPE) tissue sections for immunohistoche...
The pre-operative prediction of prognostic tumour features in the radical prostatectomy specimen usi...
Molecular prognostic markers are urgently needed in order to improve therapy decisions in prostate c...
To determine whether multiple features of immunohistochemical staining of the androgen receptor (AR)...
International audienceStandard clinical parameters fail to accurately differentiate indolent from ag...
Antibodies to assess the proliferative index of tumours are being increasingly employed together wit...
To find the best antigen retrieval buffer and retrieval time for the immunohistochemical staining of...
Pre-analytic variables, specifically cold ischemic time, have been implicated as key variables in th...
We studied the usefulness of a p63/P504S immunostain “cocktail ” in evaluation of prostate biopsy sp...
Background: Prostate cancer is a very common, but particularly heterogenic cancer form. Whilst some ...
Application of immunohistochemistry to assess the presence of prognostic tissue markers is used wide...
Immunohistochemical analysis of molecular targets in clinical tissues is increasingly becoming centr...
Background: To test the value of immunohistochemistry (IHC) staining in prostate biopsies for change...
Sectioning a whole tissue microarrray (TMA block) and storing the sections maximizes the number of s...
Sectioning a whole tissue microarrray (TMA block) and storing the sections maximizes the number of s...
Antigen decay in archival formalin-fixed paraffin-embedded (FFPE) tissue sections for immunohistoche...
The pre-operative prediction of prognostic tumour features in the radical prostatectomy specimen usi...
Molecular prognostic markers are urgently needed in order to improve therapy decisions in prostate c...
To determine whether multiple features of immunohistochemical staining of the androgen receptor (AR)...
International audienceStandard clinical parameters fail to accurately differentiate indolent from ag...
Antibodies to assess the proliferative index of tumours are being increasingly employed together wit...
To find the best antigen retrieval buffer and retrieval time for the immunohistochemical staining of...
Pre-analytic variables, specifically cold ischemic time, have been implicated as key variables in th...
We studied the usefulness of a p63/P504S immunostain “cocktail ” in evaluation of prostate biopsy sp...
Background: Prostate cancer is a very common, but particularly heterogenic cancer form. Whilst some ...